Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Placebo-controlled Trial Evaluating the Impact of High-dose Zinc Therapy and Albendazole in the Treatment of Sub-clinical Environmental Enteropathy in Rural Malawian Children

NCT01440608 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01440608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01440608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Placebo-controlled Trial Evaluating the Impact of High-dose Zinc Therapy and Albendazole in the Treatment of Sub-clinical Environmental Enteropathy in Rural Malawian Children
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2011
Completion date
December 31, 2011
Enrollment
225 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

enteropathy